Cell panel screening services

From drug discovery to patient stratification.
Screen in 2D and 3D models - spheroids or organoids.

Standard drug screens

Identify cells that respond to your therapeutics:

  • Select from a bank of standard or genetically modified cancer cell lines or send us your cell lines
  • Identify enhancers of your therapeutic using combination screening
  • Choose assay conditions that mimic the tumor micro-environment

Custom screens

Consult with your dedicated project team to define project scope:

  • Select standard or genetically modified cancer cell lines or send us your cell lines
  • Choose from a range of end-point assays
  • Opt for OncoReference data set to aid with cell line selection

Video: Combination screens

Immune cell-based assays

Understand MOA, test biosimilars or identify biomarkers:

  • Evaluate in primary T cells, NK cells, MoDC, MDSC or macrophage-based assays
  • Select from a range of end-point assays
  • Compatible with CRISPR & RNAi screens

3D models in cell panel screens

Predict which patient populations might be most responsive to a drug or biologic.

Want to discuss a project idea?

From consultation to delivery. We're always here to help.

Poster: screening using organoids

Read about the benefits of using organoids to mimic tumor microenvironments in our AACR 2019 poster - 

'Cell line panel drug screening in organoids and 3D systems.'